Bpifrance & Eurazeo invest in Doctolib

This transaction represents a significant Series G financing round for Doctolib, a leading European e-health platform. The capital infusion solidified the company's position as the most valuable technology startup in France at the time, underscoring strong investor confidence in its business model and growth trajectory in the digital health sector. The primary rationale for the fundraising was to accelerate the company's strategic initiatives across Europe. The proceeds are earmarked for several key areas: first, to deepen market penetration in its existing geographies of France, Germany, and Italy by significantly expanding its commercial teams to onboard a larger percentage of healthcare professionals. Second, the funding is intended to fuel substantial investment in product development and innovation. The company aims to evolve beyond its core appointment-booking service by launching new software solutions, such as a secure messaging service for caregivers and advanced administrative and medical software for practices. This strategic move aims to create a more integrated and indispensable ecosystem for healthcare providers. The transaction was led by prominent French investors, reflecting a desire to maintain a strong domestic influence in the shareholding structure of a company considered a national technology champion with a critical role in the country's healthcare infrastructure.